OM

Omada Health, Inc.

OMDAHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$260.2M
+53.2% YoY
Net Income
-$12.8M
+72.9% YoY
EBITDA
-$4.8M
+87.4% YoY
Free Cash Flow
$11.9M

Scan Results

Daily timeframe
DateIndicatorDetails
Sep 2 MACD Negative CrossoverHistogram -0.1235, negative momentum
Sep 1 MACD Negative CrossoverHistogram -0.0210, negative momentum
About Omada Health, Inc.

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. At a $1.39B market cap, Omada Health, Inc. ranks as a small-cap company within healthcare. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.

Where OMDA stands vs its 150-day and 200-day moving averages

As of the September 2, 2026 close, OMDA finished 33.72% above its 150-day moving average ($17.08) and 34.83% above its 200-day moving average ($16.94). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is OMDA overbought or oversold?

At the September 2, 2026 close, OMDA's RSI(14) was 42.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.39B
P/E (TTM)33.99
Fwd P/E40.94
EPS$0.67
52W Change-5.2%
ROE1.8%
Analysis

Omada Health, Inc. reports $221.7M in cash and $0 in total debt. Free cash flow comes in at $11.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 1.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $89.2M (2022) to $260.2M (2025), reflecting a 192% increase over the period.

Investors considering Omada Health, Inc. should weigh the typical risks associated with OMDA's sector, size, and financial profile against their own risk tolerance and investment objectives. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Omada Health, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms